Additionally, four miRNAs were identified that interacted to some degree with the nine HUB genes—miR-20a-5p, miR-129-2-3p, miR-124-3p, and miR-101-3p [8]—suggesting that the HUB genes are essential in promoting NAFLD and PCOS, and implying that these HUB genes could serve as potential biomarkers for diagnosis and monitoring of patients with NAFLD and/or PCOS. This evidence concerns the gene ELAVL2 and metabolic dysfunction-associated steatotic liver disease.